October 20, 2026

National HealthCare Corporation (NHC) Stock Analysis: A Steady Healthcare Contender with Robust Revenue Growth

National HealthCare Corporation (NHC), a stalwart in the healthcare sector, operates a comprehensive portfolio of skilled nursing facilities, assisted and independent living facilities, and homecare and..

ICU Medical, Inc. (ICUI) Stock Analysis: A Healthcare Innovator with Nearly 20% Potential Upside

ICU Medical, Inc. (NASDAQ: ICUI) stands as a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry. Based in San Clemente,..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unpacking a 51.64% Upside Potential in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, Alphatec Holdings, Inc. (NASDAQ: ATEC) presents an intriguing proposition. Specializing in the development and distribution of medical technologies..

Immunocore Holdings plc (IMCR) Stock Analysis: Potential Upside of Over 110% Sparks Investor Interest

Immunocore Holdings plc (NASDAQ: IMCR) is making waves in the biotechnology sector with its promising pipeline of immunomodulating medicines. With a market capitalization of $1.54 billion,..

Belite Bio, Inc (BLTE) Stock Analysis: An Impressive 55% Upside Potential Amidst Biotech Innovations

As investors scour the market for promising opportunities within the biotechnology sector, Belite Bio, Inc (BLTE) emerges as a captivating prospect. Trading on the U.S. exchange,..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unpacking a 71% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP), a pioneering Swiss biotechnology firm, is at the forefront of gene editing technology. With a market capitalization of $4.84 billion, this..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Exploring a Potential 115% Upside

Investors with an eye on the biotechnology sector may find Beam Therapeutics Inc. (NASDAQ: BEAM) an intriguing prospect, particularly given its significant potential upside of 115.60%..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Unveiling a 54.65% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is an intriguing player in the biotechnology sector, focusing on precision medicine oncology. With a market capitalization of $3.26 billion, this..

DENTSPLY SIRONA Inc. (XRAY) Investor Outlook: Unveiling Potential 50% Upside Amidst Healthcare Sector Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector specializing in medical instruments and supplies, presents an intriguing investment opportunity despite facing headwinds...

Schrodinger, Inc. (SDGR) Stock Analysis: Examining the 10.60% Potential Upside in Health Information Services

For investors with a keen interest in the healthcare sector, Schrodinger, Inc. (NASDAQ: SDGR) offers an intriguing prospect with its notable potential upside of 10.60%. As..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Exploring a Potential 93.54% Upside in the Healthcare Sector

Brookdale Senior Living Inc. (NYSE: BKD) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Denali Therapeutics Inc. (DNLI) Investor Outlook: A Compelling 98% Potential Upside Amid Strong Buy Ratings

Denali Therapeutics Inc. (NASDAQ: DNLI) is making waves in the biotechnology sector with its robust pipeline aimed at tackling neurodegenerative and lysosomal storage diseases. For investors..

Ligand Pharmaceuticals (LGND) Stock Analysis: Exploring a 16.3% Upside Potential with Strong Buy Ratings

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a formidable entity in the biotechnology sector, has captured investor attention with its robust performance metrics and a promising price target...

Concentra Group Holdings (CON) Stock Analysis: Healthcare Leader with a Strong Buy Consensus and 9% Upside Potential

Concentra Group Holdings Parent, Inc. (NASDAQ: CON) has emerged as a promising player in the healthcare sector, specifically within the medical care facilities industry. With a..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Reveals an 86% Potential Upside

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) offers a compelling narrative for investors seeking exposure in the biotechnology sector, particularly within the niche of rare and orphan diseases...

UFP Technologies (UFPT) Stock Analysis: Exploring a 21% Upside Potential in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is carving out a niche in the healthcare sector, specifically within the booming medical devices industry. With a market capitalization of..

Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator Offers a 23.62% Potential Upside

Progyny, Inc. (NASDAQ: PGNY), a trailblazer in the healthcare plans industry, is capturing investor attention with its unique approach to fertility and women’s health benefits solutions...

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Navigating a 24% Potential Upside with Strong Buy Ratings

Investors with a keen eye on the healthcare sector might find Guardian Pharmacy Services, Inc (NASDAQ: GRDN) an intriguing prospect. With a market capitalization standing at..

AtriCure, Inc. (ATRC) Investor Outlook: High Forward P/E and Steady Revenue Growth Draw Analyst Attention

For investors eyeing the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents an intriguing opportunity nestled within the medical instruments and supplies industry. With a market capitalization..

Immunovant, Inc. (IMVT) Stock Analysis: Investor Outlook Reveals Promising 76.96% Potential Upside

In the ever-competitive biotechnology sector, Immunovant, Inc. (NASDAQ: IMVT) stands out as a compelling investment opportunity, driven by its innovative approach to treating autoimmune diseases. With..

Search

Funds

October 20, 2026

Search

Funds

October 20, 2026

FTSE 100

Funds